Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-27 4:02 pm Purchase | 2023-10-20 | 13G | Tourmaline Bio, Inc. TRML | Deep Track Capital, LP | 1,815,854 8.930% | 1,815,854 (New Position) | Filing History |
| 2023-10-27 4:01 pm Purchase | 2023-10-19 | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 6.260% | 1,272,214 (New Position) | Filing History |
| 2023-07-06 4:32 pm Purchase | 2023-06-26 | 13G | Talaris Therapeutics, Inc. TALS | RA Capital Management, L.P. | 233,318 5.500% | 233,318 (New Position) | Filing History |
| 2023-04-27 2:19 pm Unchanged | 2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS | BML Investment Partners, L.P. | 218,919 5.200% | 0 (Unchanged) | Filing History |
| 2023-04-27 10:55 am Purchase | 2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS | BML Investment Partners, L.P. | 218,919 5.200% | 218,919 (New Position) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 352,217 8.400% | -28,947 (-7.59%) | Filing History |
| 2022-08-09 4:02 pm Sale | 2022-07-31 | 13G | Talaris Therapeutics, Inc. TALS | BlackRock Inc. BLK | 198,430 4.800% | -41,116 (-17.16%) | Filing History |
| 2022-02-28 4:03 pm Purchase | 2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS | Qiming U.S. Healthcare GP II LLC | 298,340 7.200% | 298,340 (New Position) | Filing History |
| 2022-02-14 5:01 pm Unchanged | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | VIKING GLOBAL INVESTORS LP | 328,962 8.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 06:30 am Sale | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 381,164 9.000% | -222 (-0.06%) | Filing History |
| 2022-02-11 4:24 pm Purchase | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | BXG Redhawk S.a r.l. | 808,932 19.600% | 808,932 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | BlackRock Inc. BLK | 239,547 5.800% | 239,547 (New Position) | Filing History |
| 2021-05-21 4:28 pm Purchase | 2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS | Longitude Capital Partners III LLC | 322,078 7.800% | 322,078 (New Position) | Filing History |
| 2021-05-21 4:08 pm Purchase | 2021-05-11 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 381,386 9.200% | 381,386 (New Position) | Filing History |
| 2021-05-17 1:25 pm Purchase | 2021-05-07 | 13G | Talaris Therapeutics, Inc. TALS | VIKING GLOBAL INVESTORS LP | 328,962 8.200% | 328,962 (New Position) | Filing History |